Lexeo Therapeutics Inc. C... (LXEO)
NASDAQ: LXEO
· Real-Time Price · USD
4.71
-0.08 (-1.67%)
At close: Aug 15, 2025, 3:59 PM
4.72
0.21%
After-hours: Aug 15, 2025, 05:36 PM EDT
Lexeo Therapeutics Common Stock Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
PE Ratio | -0.88 | -2.1 | -2.53 | -6.06 | -5.11 | -6.46 | -3.14 | -4.7 | -3.39 | -4.34 | -3.71 | -4.18 | -5.36 |
PEG Ratio | -0.04 | 0.27 | -0.06 | 0.36 | -0.11 | 0.18 | -0.06 | 0.17 | -0.12 | 0.29 | -0.28 | -0.15 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 476.37 | 6.84K | 3.13K |
PB Ratio | 1.30 | 1.86 | 2.15 | 3.12 | 2.42 | 3.23 | -1.55 | -1.76 | 4.70 | -2.24 | n/a | n/a | n/a |
P/FCF Ratio | -5.29 | -7.69 | -16.72 | -25.29 | -29.45 | -26.08 | -18.07 | -19.12 | -13.77 | -15.12 | -20.75 | -22.44 | -17.54 |
P/OCF Ratio | -5.29 | -7.68 | -16.79 | -25.56 | -29.83 | -26.22 | -18.13 | -19.17 | -13.77 | -15.21 | -21.46 | -22.89 | -17.74 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22.2 | -298.65 | -176.44 |
Debt / Equity Ratio | 0.11 | 0.08 | 0.07 | 0.07 | 0.06 | 0.10 | -0.1 | -0.09 | 0.24 | -0.12 | n/a | n/a | n/a |
Quick Ratio | 3.42 | 5.52 | 5.95 | 9.38 | 9.16 | 7.21 | 1.69 | 3.57 | 4.47 | 5.58 | n/a | n/a | n/a |
Current Ratio | 3.42 | 5.52 | 5.95 | 9.38 | 9.16 | 7.21 | 1.69 | 3.57 | 4.47 | 5.58 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -1.21K | -912.73 | -901.23 | -672.86 | -629.49 | -299.48 | -389.87 | -263.68 | -385.8 | -281.43 | -602.83 | -1.7K | n/a |
Return on Equity | -0.37 | -0.22 | -0.21 | -0.13 | -0.12 | -0.12 | 0.12 | 0.09 | -0.35 | 0.13 | n/a | n/a | n/a |
Return on Assets | -0.26 | -0.18 | -0.17 | -0.11 | -0.1 | -0.1 | -0.37 | -0.21 | -0.24 | -0.15 | n/a | n/a | n/a |
Return on Invested Capital | -0.35 | -0.22 | -0.21 | -0.13 | -0.12 | -0.12 | -0.53 | -0.26 | -0.29 | -0.18 | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 | -8.49 | 0.92 |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -32.12 | -409.27 | -146.13 |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -32.12 | -409.27 | -146.13 |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -32.92 | -413.81 | -146.34 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -31.42 | -409.03 | -146.26 |